Compare HCSG & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HCSG | EVO |
|---|---|---|
| Founded | 1976 | 1993 |
| Country | United States | Germany |
| Employees | N/A | N/A |
| Industry | Assisted Living Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.1B |
| IPO Year | N/A | 2021 |
| Metric | HCSG | EVO |
|---|---|---|
| Price | $17.49 | $3.20 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 5 | 1 |
| Target Price | ★ $19.40 | $7.00 |
| AVG Volume (30 Days) | ★ 928.2K | 250.0K |
| Earning Date | 02-11-2026 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.54 | N/A |
| Revenue | ★ $1,808,303,000.00 | $887,396,457.00 |
| Revenue This Year | $9.23 | N/A |
| Revenue Next Year | $5.28 | $8.52 |
| P/E Ratio | $32.12 | ★ N/A |
| Revenue Growth | ★ 6.26 | N/A |
| 52 Week Low | $9.13 | $2.84 |
| 52 Week High | $20.26 | $4.80 |
| Indicator | HCSG | EVO |
|---|---|---|
| Relative Strength Index (RSI) | 32.41 | 54.56 |
| Support Level | $19.29 | $3.08 |
| Resistance Level | $19.88 | $3.18 |
| Average True Range (ATR) | 0.67 | 0.08 |
| MACD | -0.18 | 0.03 |
| Stochastic Oscillator | 17.82 | 92.31 |
Healthcare Services Group Inc is a provider of housekeeping and facility management services to the healthcare industry. The company operates two business segments, both contributing roughly equally to the company's revenue: Housekeeping, laundry, linen, and other services; and Dietary department services. Housekeeping includes management of clients' housekeeping departments, cleaning, disinfecting and sanitizing, laundry, bed linen, and uniform services. Dietary consists of food purchasing, meal preparation, and providing dietitian consulting services. Its clients are nursing homes, retirement complexes, rehabilitation centers, and hospitals in the United States of America.
Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.